STRATA Appoints Erica Jordan CEO
Analysis based on 6 articles · First reported Jul 28, 2026 · Last updated Jul 28, 2026
The appointment signals a strategic shift towards scaling commercial operations and capitalizing on expanded CPT code coverage. The market may view this positively as Jordan's track record in revenue growth and sales transformation could enhance STRATA's market position.
STRATA Skin Sciences, a medical technology company specializing in excimer laser therapy for dermatologic conditions, announced the appointment of Erica Jordan as Chief Executive Officer, effective July 12, 2026. Jordan, a medical device commercial veteran, previously served as Chief Commercial Officer at Revance Therapeutics and held leadership roles at Envista Holdings Corporation, GE HealthCare, Philips Healthcare, Fujifilm Medical, Siemens Medical Solutions, and GE Healthcare. She succeeds Dr. Dolev Rafaeli, who served as CEO for a long tenure. Chairperson Dr. TJ Geiger expressed confidence in Jordan's ability to drive commercial success and expand market reach.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard